Madrigal Pharmaceuticals ... (MDGL)
315.10
-26.17 (-7.67%)
At close: Mar 03, 2025, 3:59 PM
313.47
-0.52%
After-hours: Mar 03, 2025, 04:17 PM EST
Madrigal Pharmaceuticals Analyst Ratings
Total Analysts
13
Consensus Rating
Buy
Price Target
383.5
Upside
21.71
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Date |
David Lebovitz (1.03)
| Citigroup | Strong Buy | Maintains | 378 469 | Feb 27, 2025 |
Ed Arce (0.01)
| HC Wainwright & Co. | Strong Buy | Maintains | 400 405 | Feb 27, 2025 |
Ed Arce (0.01)
| HC Wainwright & Co. | Strong Buy | Maintains | 390 400 | Jan 14, 2025 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.